Menadiol Diphosphoric Acid

CHEMBL1201348 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
334.2 g/mol
LogP
0.2
Phase
4

This water-soluble form of vitamin K3 (menadione) was used to treat vitamin K deficiency and the bleeding problems associated with it, particularly in patients with liver disease or malabsorption syndromes. Water-soluble vitamin K forms were developed because natural vitamin K is fat-soluble and requires adequate fat absorption.

Molekularmasse

334,1600 g/mol

LogP

0,20

TPSA

134,00 Ų

Lipinski-Regel der Fünf

Bestanden

Wirkmechanismus

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cc(OP(=O)(O)O)c2ccccc2c1OP(=O)(O)O

InChI

InChI=1S/C11H12O8P2/c1-7-6-10(18-20(12,13)14)8-4-2-3-5-9(8)11(7)19-21(15,16)17/h2-6H,1H3,(H2,12,13,14)(H2,15,16,17)

Molecular Formula

C11H12O8P2

HBD / HBA

4 / 8

Rotierbare Bindungen

4

Schwere Atome

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This water-soluble form of vitamin K3 (menadione) was used to treat vitamin K deficiency and the bleeding problems associated with it, particularly in patients with liver disease or malabsorption syndromes. Water-soluble vitamin K forms were developed because natural vitamin K is fat-soluble and requires adequate fat absorption.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Menadiol Diphosphoric Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201348. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 8556. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.